Quintiles Transnational Holdings Inc (Q) : Brc Investment Management scooped up 42,910 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 26, 2016. The investment management firm now holds a total of 301,678 shares of Quintiles Transnational Holdings Inc which is valued at $20,836,899.Quintiles Transnational Holdings Inc makes up approximately 3.09% of Brc Investment Management’s portfolio.
Quintiles Transnational Holdings Inc opened for trading at $69.47 and hit $69.665 on the upside on Monday, eventually ending the session at $69.1, with a gain of 0.04% or 0.03 points. The heightened volatility saw the trading volume jump to 14,85,734 shares. Company has a market cap of $8,250 M.
Other Hedge Funds, Including , Winslow Evans Crocker reduced its stake in Q by selling 1,000 shares or 22.22% in the most recent quarter. The Hedge Fund company now holds 3,500 shares of Q which is valued at $245,140. Quintiles Transnational Holdings Inc makes up approx 0.07% of Winslow Evans Crocker’s portfolio.Acadian Asset Management reduced its stake in Q by selling 261,294 shares or 89.43% in the most recent quarter. The Hedge Fund company now holds 30,885 shares of Q which is valued at $2,164,730. Quintiles Transnational Holdings Inc makes up approx 0.01% of Acadian Asset Management’s portfolio. Lenox Wealth Advisors sold out all of its stake in Q during the most recent quarter. The investment firm sold 50 shares of Q which is valued $3,505.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.89 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.86. The company had revenue of $1108.00 million for the quarter, compared to analysts expectations of $1118.63 million. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.72 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Downgraded by Sun Trust Rbsn Humphrey to ” Neutral” on Mar 28, 2016. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Perform” on Feb 11, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.